President Trump issued an Executive Order instructing federal agencies to implement a variety of drug pricing reforms. The Executive Order addresses drug pricing from several different angles, ...

Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.

Rules on conditions of participation, billing disputes and healthcare-associated infections are among those the industry wants the government to relax or revoke.

Many Medicare quality measures are only loosely related to actual patient outcomes. It’s time to deregulate the system, ...

Below is a tracker of healthcare-related executive orders (EOs) issued by the Trump administration, including overviews of ...

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.

Congress returns to Washington from its spring recess to face a jam-packed agenda, with extending tax cuts its top priority.

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...

According to KFF, the new executive order directs the Department of Health and Human Services to work with Congress to ...

Two leading voices in the hospital sector are offering sharply different perspectives on the implications of an April 15 executive order issued by President Donald Trump aimed at reducing drug prices, ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Medicare and Social Security ... discourse once again after President Donald Trump on Tuesday signed an executive order focused on lowering U.S. drug prices. Meanwhile, his predecessor blasted ...